Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26:224-230
Published online before print November 3, 2005, doi: 10.1161/01.ATV.0000194076.84568.81
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
26/1/224    most recent
01.ATV.0000194076.84568.81v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kato, H.
Right arrow Articles by Kanakura, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kato, H.
Right arrow Articles by Kanakura, Y.
Related Collections
Right arrow Obesity
Right arrow Arterial thrombosis
Right arrow Platelet function inhibitors
Right arrow Acute coronary syndromes
Right arrow Platelets
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26:224.)
© 2006 American Heart Association, Inc.


Thrombosis

Adiponectin Acts as an Endogenous Antithrombotic Factor

Hisashi Kato; Hirokazu Kashiwagi; Masamichi Shiraga; Seiji Tadokoro; Tsuyoshi Kamae; Hidetoshi Ujiie; Shigenori Honda; Shigeki Miyata; Yoshinobu Ijiri; Junichiro Yamamoto; Norikazu Maeda; Tohru Funahashi; Yoshiyuki Kurata; Iichiro Shimomura; Yoshiaki Tomiyama; Yuzuru Kanakura

From the Departments of Hematology and Oncology (H. Kato, H. Kashiwagi, M.S., S.T., T.K., H.U., Y.T., Y.Ka.) and Internal Medicine and Molecular Science (N.M., T.F., I.S.), Graduate School of Medicine, Osaka University, Suita; National Cardiovascular Center Research Institute (S.H.), Suita, Osaka; Division of Transfusion Medicine (S.M.), National Cardiovascular Center, Suita, Osaka; Department of Nutrition Management (Y.I.), Faculty of Health Science, Hyogo University, Kakogawa, Hyogo; Laboratory of Physiology, Faculty of Nutrition (J.Y.) and High Technology Research Centre (J.Y.), Kobe Gakuin University, Kobe; and Department of Blood Transfusion (Y.Ku.), Osaka University Hospital, Suita, Japan.

Correspondence to Yoshiaki Tomiyama, Osaka University, Department of Hematology and Oncology, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan. E-mail yoshi{at}hp-blood.med.osaka-u.ac.jp

Objective— Obesity is a common risk factor in insulin resistance and cardiovascular diseases. Although hypoadiponectinemia is associated with obesity-related metabolic and vascular diseases, the role of adiponectin in thrombosis remains elusive.

Methods and Results— We investigated platelet thrombus formation in adiponectin knockout (APN-KO) male mice (8 to 12 weeks old) fed on a normal diet. There was no significant difference in platelet counts or coagulation parameters between wild-type (WT) and APN-KO mice. However, APN-KO mice showed an accelerated thrombus formation on carotid arterial injury with a He-Ne laser (total thrombus volume: 13.36±4.25x107 arbitrary units for APN-KO and 6.74±2.87x107 arbitrary units for WT; n=10; P<0.01). Adenovirus-mediated supplementation of adiponectin attenuated the enhanced thrombus formation. In vitro thrombus formation on a type I collagen at a shear rate of 250 s–1, as well as platelet aggregation induced by low concentrations of agonists, was enhanced in APN-KO mice, and recombinant adiponectin inhibited the enhanced platelet aggregation. In WT mice, adenovirus-mediated overexpression of adiponectin additionally attenuated thrombus formation.

Conclusion— Adiponectin deficiency leads to enhanced thrombus formation and platelet aggregation. The present study reveals a new role of adiponectin as an endogenous antithrombotic factor.

We demonstrated an enhanced thrombus formation and platelet aggregation in adiponectin knockout mice and that adenovirus-mediated supplementation of adiponectin attenuated the enhanced thrombus formation. In wild-type mice, overexpression of adiponectin attenuated thrombus formation. These findings reveal a new role of adiponectin as an endogenous antithrombotic factor.


Key Words: acute coronary syndromes • obesity • platelets • thrombosis




This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
K. Ohashi, N. Ouchi, K. Sato, A. Higuchi, T.-o Ishikawa, H. R. Herschman, S. Kihara, and K. Walsh
Adiponectin Promotes Revascularization of Ischemic Muscle through a Cyclooxygenase 2-Dependent Mechanism
Mol. Cell. Biol., July 1, 2009; 29(13): 3487 - 3499.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
H. Teoh, A. Quan, K. W. A. Bang, G. Wang, F. Lovren, V. Vu, J. J. Haitsma, P. E. Szmitko, M. Al-Omran, C.-H. Wang, et al.
Adiponectin deficiency promotes endothelial activation and profoundly exacerbates sepsis-related mortality
Am J Physiol Endocrinol Metab, September 1, 2008; 295(3): E658 - E664.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. F. Bodary
Links Between Adipose Tissue and Thrombosis in the Mouse
Arterioscler Thromb Vasc Biol, November 1, 2007; 27(11): 2284 - 2291.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. J. Westrick, M. E. Winn, and D. T. Eitzman
Murine Models of Vascular Thrombosis
Arterioscler Thromb Vasc Biol, October 1, 2007; 27(10): 2079 - 2093.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
H. Katagiri, T. Yamada, and Y. Oka
Adiposity and Cardiovascular Disorders: Disturbance of the Regulatory System Consisting of Humoral and Neuronal Signals
Circ. Res., July 6, 2007; 101(1): 27 - 39.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
J. D. Knudson, G. M. Dick, and J. D. Tune
Adipokines and Coronary Vasomotor Dysfunction
Experimental Biology and Medicine, June 1, 2007; 232(6): 727 - 736.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. E. Szmitko, H. Teoh, D. J. Stewart, and S. Verma
Adiponectin and cardiovascular disease: state of the art?
Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1655 - H1663.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
R. Wolk, P. Berger, R. J. Lennon, E. S. Brilakis, D. E. Davison, and V. K. Somers
Association between plasma adiponectin levels and unstable coronary syndromes
Eur. Heart J., February 1, 2007; 28(3): 292 - 298.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
G. A. Laughlin, E. Barrett-Connor, S. May, and C. Langenberg
Association of Adiponectin with Coronary Heart Disease and Mortality: The Rancho Bernardo Study
Am. J. Epidemiol., January 15, 2007; 165(2): 164 - 174.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
E. Cavusoglu, C. Ruwende, V. Chopra, S. Yanamadala, C. Eng, L. T. Clark, D. J. Pinsky, and J. D. Marmur
Adiponectin is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction in patients presenting with chest pain
Eur. Heart J., October 1, 2006; 27(19): 2300 - 2309.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. F. Bodary and D. T. Eitzman
Adiponectin: Vascular Protection From the Fat?
Arterioscler Thromb Vasc Biol, February 1, 2006; 26(2): 235 - 236.
[Full Text] [PDF]